NeoGenomics - 53 Year Dividend History | NEO
Historical dividend payout and yield for NeoGenomics (NEO) since 1971. The current TTM dividend payout for NeoGenomics (NEO) as of November 19, 2024 is $0.00. The current dividend yield for NeoGenomics as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.972B |
$0.592B |
|
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
